Shift of Choline/Betaine Pathway in Recombinant for Cobalamin Biosynthesis and Abiotic Stress Protection.

The B12-producing strains DSM 1650 and sp. CCUG 2519 (both formerly ), with the most distributed pathway among bacteria for exogenous choline/betaine utilization, are promising recombinant hosts for the endogenous production of B12 precursor betaine by direct methylation of bioavailable glycine or non-proteinogenic -alanine. Two plasmid-based de novo betaine pathways, distinguished by their enzymes, have provided an expression of the genes encoding for -methyltransferases of the halotolerant cyanobacterium or plant to synthesize the internal glycine betaine or -alanine betaine, respectively. These betaines equally allowed the recombinant pseudomonads to grow effectively and to synthesize a high level of cobalamin, as well as to increase their protective properties against abiotic stresses to a degree comparable with the supplementation of an exogenous betaine. Both de novo betaine pathways significantly enforced the protection of bacterial cells against lowering temperature to 15 °C and increasing salinity to 400 mM of NaCl. However, the expression of the single plant-derived gene for the -alanine-specific -methyltransferase additionally increased the effectiveness of exogenous glycine betaine almost twofold on cobalamin biosynthesis, probably due to the ' ability to use two independent pathways, their own choline/betaine pathway and the plant -alanine betaine biosynthetic pathway.